How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults?

Abstract

The rate of aging has increased globally during recent decades and has led to a rising burden of age-related diseases such as cardiovascular disease (CVD). At the molecular level, epigenetic modifications have been shown recently to alter gene expression during the life course and impair cellular function. In this regard, several CVD risk factors, such as lifestyle and environmental factors, have emerged as key factors in epigenetic modifications within the cardiovascular system. In this study, we attempted to summarized recent evidence related to epigenetic modification, inflammation response, and CVD in older adults as well as the effect of lifestyle modification as a preventive strategy in this age group. Recent evidence showed that lifestyle and environmental factors may affect epigenetic mechanisms, such as DNA methylation, histone acetylation, and miRNA expression. Several substances or nutrients such as selenium, magnesium, curcumin, and caffeine (present in coffee and some teas) could regulate epigenetics. Similarly, physical inactivity, alcohol consumption, air pollutants, psychological stress, and shift working are well-known modifiers of epigenetic patterns. Understanding the exact ways that lifestyle and environmental factors could affect the expression of genes could help to influence the time of incidence and severity of aging-associated diseases. This review highlighted that a healthy lifestyle throughout the life course, such as a healthy diet rich in fibers, vitamins, and essential elements, and specific fatty acids, adequate physical activity and sleep, smoking cessation, and stress control, could be useful tools in preventing epigenetic changes that lead to impaired cardiovascular function.

Fat‐Diets in Perinatal Stages Altered Nr3c2‐Mediated Ca2+ Currents in Mesenteric Arteries of Offspring Rats

“…These epigenetic modifications mainly are mediated by DNA methylation, which plays crucial roles in developmental origins of cardiovascular diseases. [24][25][26] Dramatic DNA methylation changes often occur during critical developmental stages in life, which may be susceptible/responsive to environmental cues. [27,28] Gene expression could be enhanced through a decrease in DNA methylation of its promoter CpG islands.…”

A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research

“…The majority of the clinical studies cited measured miRNAs immediately post-treatment or within 6 months of the end of treatment and only two studies took samples during the chemotherapy treatment period [ 28 , 31 ]. The temporal variation in circulating microRNA expression may not necessarily be related to cardiotoxicity but to other comorbidities, functional pathways or patient-related factors [ 141 ]. Expression changes of miRNAs related to skeletal muscle and the cardiovascular system have been noted to be influenced by exercise for up to 24 hrs [ 142 ].…”

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors

“…One of the most important and independent risk factors for heart disease is diabetes mellitus, which predisposes to the development of coronary heart disease (CHD), cerebral vascular disease (CVAs) and/or peripheral arterial disease (PAD) [5][6][7]. A growing body of evidence demonstrated that epigenetic modifications play an important role in the development and progression of CVD affecting vascular and cardiac function in patients with diabetes [8].…”